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During the last 2 decades, the revolution in treating acute 
myocardial infarction has largely originated from rhe con- 
cept hat myocardial infarct size could be reduced by timely 
coronary artery reperfusion. Thrombolytic therapy has been 
shown (1) to reduce myocardial Infarct size and to improve 
left ventricular function and survival. In the late 1970s it
became clear that postinfarction utcome is dependent on 
factors other than acute reduction ofmyocardiai nfarct sine, 
an event that usually occurs within the 1st 24 h of coronary 
occlusion. Events occurring several days, weeks or perhaps 
even months after the initial coronary occlusion might ulti- 
mately determine patient outcome. Numerous studies (2-4) 
showed that topographic changes inthe left ventricle after 
coronary occlusion could contribute othis outcome. 
Early infarct expansion a d left ventricular topographic 
changes. Within the 1st week of coronary artery occlusion 
the myocardial nfarct may exhibit thinning and stretching of 
the necrotic myocytes (2,3) (Fig. 1). A recent study suggests 
(5) that early collagen breakdown after myocardial nfarction 
may contribute o the slippage of myocytes past each other. 
Early infarct expansion and left ventricular dilation occur- 
ring within the 1st week can be diagnosed by simple nonin- 
vasive techniques such as two-dimensional echocardiog- 
raphy (6). Patients with infarct expansion are prone to 
several deleterious clinical cocsequences, including conges- 
tive heart failure, ventricular rupture, papillary muscle rup- 
ture, ventricular septal defect and death (3). Experimental 
studies (7,8) have shown that certain pharmacologic agents 
(steroids; ome nonsteroid anti-inflammatory agents, but not 
aspirin) can exacerbate myocardial infarct expansion. Be- 
ymd this early infarct expansion, continued topographic 
chadges may occur within the left ventricle (4). Smaller 
infarcts are likely to exhibit continued scar contraction. 
However, moderate-sized to large infarcts may exhibit con- 
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tinued expansion of the infarct zone, expansion of the 
noninfarct zone with eccentric hypertropby, and regional 
and global left ventricular dilation (Fig. 1, A t ) (4,9,10). %+ 
is now well accepted (IO) that he degree of ve~~~c~lar 
dilation occurring after an acute myocardial infarction isan 
important predictor f death at 1 year. Those patients with 
dilated left ventricle are much more likely to die. The goo 
news is that his process of left ventricular remodeling does 
not occur instantly, can be diagnosed by noninvasive imag- 
ing (two-dimensional echocardiography, radionuclide ven- 
triculography, magnetic resonance imaging) and cam be 
treated. Unlike the decision to give thro 
which must be made rapidly and often u 
decision to try to reduce or prevent left ventricular remod- 
eling can be made in a more systematic fashio 
appropriate noninvasive (or invasive) data have 
ered. 
Several studies (I l-15) have shown that lon 
apy with angiotensin-converting enzyme inhibitors uch as 
captopril, even when administered a few weeks after the 
initial myocardial nfarction, can reduce the degree of postin- 
far&on left ventricular dilation (Fig. IG) (1 l-15), improve 
exercise tolerance (12) and improve survival (13,14). Ni- 
trates also have been shown to reduce infarct expansion (16). 
The mechanism bywhich these vasodilators are capable of 
preventing infarct expansion may be a reduction of wall 
stress by a reduction of preload or afterload, or both. We 
believe that he mechanism is unlikely to be a reduction i  
afterload alone, because calcium channel blockers do not 
seem to prevent infarct expansion in experimental models 
(17). In addition, it is conceivable that the tissue renin- 
angiotensin system might be playing a role in modulating 
topographic alterations of the ventricle. 
The present s udy. The study by Leung and Lau (18) in 
this issue of the Journal makes the important observation 
that in patients who received thrombolytic therapy, the 
degree of residual stenosis of the infarct-related artery 
before hospital discharge was a determinant of he degree of 
left ventricular dilation observed at6 months and 1 year after 
infarction. The study implies that another potential therapy 
for left ventricular dilation tier myocardial infarction may 
be angioplasty. The timing at which angioplasty would need 
to be performed in order to prevent or reduce left ventricular 
dilation is not clear. Obviously, early successful and sus- 
tained reperfusion by any means (thrombolysis or angio- 
plasty) will lead to a smaller subendocardial infarct that is 
less likely to expand (Fig. 1 E). However, even late reperfu- 
siGn (too late to reduce infarct size) has been shown m 
experimental models to prevent infarct expansion and left 
ventricular dilation (Fig. 1F) (19,20). How late is too late 
remains to be determined. The mechanism wherety late 
reperfusion might reduce infmi expansion is uot known. 
Perhaps late reperfusion preserves a thin rim of epicardial 
myocardial cells or epicardial collagen that is enough to 
battle the infarct zone and prevent expansion. Another 
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monihs, continued left ventricular dilation occurs. The noninfarct as well as the infarct zone 
lengthens. Eccentric hypertrophy (with dilation disproportionate to ~y~e~ro~by) develops 
ch occurs with volume ov 
show potential therapy. Early re~e~~s~o~ (er) (thrombolysis or 
h) after coronary occlusio duces myocardial infarct size. The infarct 
a) is subendocardial with salvage of tissue in the subepicardium of the risk 
Infarct expansion does not occur. F, Late reperfusion (Ir) (tbrombolysis 
0th) may result in a large infarct but experimental studies suggest rbat less 
left ventricular dilation and expansion occur with this t~~era~y. T e lesl;lts of Leung and Lau 
(IS) imply (hat, for the situations in ne!s E and F, the less the residual stenosis, the less the 
degree of left ventricular dilation. ence, angioplasty (wh uld reduce the degree of 
residual stenosis) might have a treatment advanlage over t o!ysis alone. Hearts With 
residual stenosis of the infarct-related artery but with ~e~e~~sion might have 
intermediate degrees of prote ventricular dilatioo. Also implied is that if reocclu- 
sion occurs in the situation sh ei E or F (and the previou 
no longer patent), left ventric 
Finally, the situation shown I 
(acei) can prevent or reduce the degree of left ventricular dilation after coronary artery 
occlusion. Nitrates can also prevent this left ventricular dilation. These agents may be 
especially useful in cases of moderate to large infarction in which initial attempts at 
reperf;lsiou were unsuccessful or reocclusion ccurred after initially successful reperfusion. 
Preliminary data from the Survival and Ventricular Enlargement trial presented by Pfeffer el 
al. at the 1992 ACC Scientific Session suggested that long-term captopril therapy after 
infarction improved survival, reduced heart failure and reduced reinfarction rates. 
theory is that the turgor within the reperfused vasculature 
acts as an epicardial b 
The study of Leun d Lau (18) also im 
quality of reperfusion after acute myocardial infarction is 
important. The more complete and permanent the reperfu- 
sion and the less the residual stenosis of the infarct-related 
artery, the less chance that left ventricular dihtim will 
develop after infarction. Thus, angioplasty, which will re- 
duce the degree of resadual coronary artery stenosis due to 
atherosclerosis, may be a better therapy than thrombolysis 
alone (which will not do this) for preventing topographic 
changes to the left ventricle. Presumably the angioplasty 
would not need to be performed in the acute phase of 
infarction. 
Conchsims. There are several points in the natural his- 
tory of myocardial infarction at which the clinician may 
improve outcome (Fig. 1). Acute early reperfusion will 
reduce infarct size (Fig. 1E) and improve left ventricular 
iu;,cZiCIn a;rJ Slrrkk2d. S al . ,2Ue;y, k dile~~iou3 ccnse- 
quences of progressive l ft ventricular dilation may be 
prevented by other interventions including angiotensin- 
converting enzyme inhibitors (Fig. lG), nitrates and now, as 
suggested by Leung and Lau (lg), possibly angioplasty. 
Clinical trials are needed to determine whether angioplasty 
after infarction will reduce the degree of ultimate l ft ven- 
tricular dilation to a greater extent than thrombolysis alone, 
and to determine the time after infarction tha,r an 
- 
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